We found that an ASO mediating degradation of Glis2 mRNA was effective in reducing polycystic kidney disease severity and attendant tissue level changes including cyst cell proliferation and inflammatory and pro-fibrotic changes in the kidney. The gene discussed is GLIS2; the disease is polycystic kidney disease.